Brooke Robert T. 4
4 · Genesis Biopharma, Inc · Filed Apr 13, 2011
Insider Transaction Report
Form 4
Brooke Robert T.
DirectorPresident, CEO10% Owner
Transactions
- Other
Common Stock
2011-03-25−1,500,000→ 4,440,008 total
Footnotes (1)
- [F1]These shares were cancelled pursuant to the terms of an Advisory Agreement entered into effective February 7, 2011, by the issuer and Mr. Brooke.